Zymeworks

ZYMENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.719 B

$23.54 +1.77%

Close of 7 Aug 2026

Revenue

$106.0M

#2496 by revenue

Earnings

-$81.1M

Loss-making

Shares outstanding

70,959,241

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#128Ani PharmaceuticalsANIP$1.76B
#129SepternaSEPN$1.75B
#130ZymeworksZYME$1.72B
#131Obsidian TherapeuticsOBX$1.70B
#132AnaptysbioANAB$1.68B

Where these numbers come from

Share counts and financials for Zymeworks are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.